Alfa Chemistry Materials is specialized in material chemistry and offers an extensive catalog of materials in a wide range of applications, including Metals and Materials, 3D Printing Materials, Biomaterials.
[6,6]-Pentadeuterophenyl C61 butyric acid methyl ester (PC60BM) is a deuterated fullerene that can be used as an acceptor molecule. It has a fullerene as the core and deuterium and benzyl as the attachment. The deuterium atoms facilitate an increase in the quantum efficiency of the electrochemical devices. Uses: Pc60bm is a conjugating polymer that can be used as an alternative to the conventionally used pcbm for the organic electronic based applications, which include polymeric solar cells and organic light emitting diodes (oleds). Group: Carbon nano materials organic solar cell (opv) materials. Alternative Names: 1-[3-(Methoxycarbonyl)propyl]-1-pentadeuterophenyl-[6.6] C61,d5-PCBM. CAS No. 749898-80-4. Pack Sizes: 100 mg in glass insert. Molecular formula: 915.91. [2H]c1c ([2H]) c ([2H]) c (c ([2H]) c1[2H]) C2 (CCCC (=O) OC) [C]3=4c5c6c7c8c9c% 10c (c% 11c% 12c3c% 13c5c% 14c% 15c6c% 16c7c% 17c9c% 18c% 19c% 10c% 20c% 11c% 21c% 12c% 22c% 13c% 23c% 14c% 24c% 15c% 25c% 16c% 26c% 17c% 18c% 27c% 28c% 19c% 20c% 29c% 21c% 30c% 22c% 23c% 31c% 24c% 32c% 25c% 26c% 27c% 33c% 28c% 29c% 30c% 31c% 32% 33) [C]2=48.
[6,6]-Phenyl-C61 butyric acid butyl ester
[6,6]-Phenyl-C61 butyric acid butyl ester ([60]PCB-C4) is a fullerene derivative that is used as an acceptor molecule with good field effect mobility in organic electronics. It has a structural similarity to PCBM based fullerene and its aliphatic groups facilitate an increase in its solubility. Uses: [60]pcb-c4 is a conducting polymer, which can be used in a variety of applications such as organic photovoltaic cells (opvs) and bulk heterojunction (bhj) solar cells. Group: Carbon nano materials organic field effect transistor (ofet) materials organic solar cell (opv) materials. Alternative Names: 1-(3-Butoxycarbonylpropyl)-1-phenyl-[6.6]C61,PCBB,PCB-C4. CAS No. 571177-66-7. Pack Sizes: 1 g in glass bottle. Product ID: butyl 4-[(28S, 30R)-29-phenyl-29-heptadecacyclo[10.8.8.813, 17.55, 28.04, 22.08, 32.09, 30.016, 40.020, 35.021, 36.023, 33.024, 37.025, 31.026, 38.027, 41.028, 30.034, 39]hentetraconta-1(20), 2, 4, 6, 8, 10, 12, 14, 16, 18, 21, 23, 25(31), 26, 32, 34, 36, 38, 40-nonadecaenyl]butanoate. Molecular formula: 952.96. Mole weight: C55H30O2. CCCCOC (=O) CCCC2 (c1ccccc1) C34c5c6c7c8c9c% 10c (c% 11c% 12c3c% 13c5c% 14c% 15c6c% 16c7c% 17c9c% 18c% 19c% 10c% 20c% 11c% 21c% 12c% 22c% 13c% 23c% 14c% 24c% 15c% 25c% 16c% 26c% 17c% 18c% 27c% 28c% 19c% 20c% 29c% 21c% 30c% 22c% 23c% 31c% 24c% 32c% 25c% 26c% 27c% 33c% 28c% 29c% 30c% 31c% 32% 33) C248. InChI= 1S / C55H30O2 / c1-2-3-22-57-34 (56) 10-7-21-5
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 6arm-PEG. Molecular formula: average Mn 17000.
6-Bromo-2,2'-bipyridyl
6-Bromo-2,2'-bipyridyl. Group: Ligands for functional metal complexes. Alternative Names: 6-Bromo-2,2-bipyridine; CTK4A3518; DB-027142; J-400771; AM84321; AJ-68924; 6-bromo-2-(2-pyridyl)pyridine; CB-2545; NCRIDSGPLISUEU-UHFFFAOYSA-N; MFCD01318953. CAS No. 10495-73-5. Product ID: 2-bromo-6-pyridin-2-ylpyridine. Molecular formula: 235.084g/mol. Mole weight: C10H7BrN2. C1=CC=NC(=C1)C2=NC(=CC=C2)Br. InChI=1S/C10H7BrN2/c11-10-6-3-5-9 (13-10)8-4-1-2-7-12-8/h1-7H. NCRIDSGPLISUEU-UHFFFAOYSA-N.
6-Bromo-4,4'-dimethyl-2,2'-bipyridyl
6-Bromo-4,4'-dimethyl-2,2'-bipyridyl. Group: Ligands for functional metal complexes. Alternative Names: 6-Bromo-4,4'-Dimethyl-2,2'-Bipyridyl; 2-Bromo-4-Methyl-6-(4-Methylpyridin-2-Yl)Pyridine. CAS No. 850413-36-4. Product ID: 2-bromo-4-methyl-6-(4-methylpyridin-2-yl)pyridine. Molecular formula: 263.13. Mole weight: C12H11BrN2. CC1=CC(=NC=C1)C2=NC(=CC(=C2)C)Br. InChI=1S/C12H11BrN2/c1-8-3-4-14-10 (5-8)11-6-9 (2)7-12 (13)15-11/h3-7H, 1-2H3. UEJJXCRFGURPDR-UHFFFAOYSA-N. 97%.
Alfa Chemistry offers high-purity 6'-(Diethylamino)-1',2'-benzofluoran products for various research purposes. Please contact us by email if you do not find the specification you are looking for on this page. Uses: This technique has been applied to print on commuter passes or prepaid cards. by combining acid-generating methods with the coloring mechanism, new applications can be expected for these materials. Group: Pressure & heat sensitive recording materials heat & pressure sensitive dyes other materials. CAS No. 26628-47-7. Product ID: 9'-(diethylamino)spiro[2-benzofuran-3,12'-benzo[a]xanthene]-1-one. Molecular formula: 421.5. Mole weight: C28H23NO3. CCN (CC)C1=CC2=C (C=C1)C3 (C4=CC=CC=C4C (=O)O3)C5=C (O2)C=CC6=CC=CC=C65. InChI=1S/C28H23NO3/c1-3-29 (4-2)19-14-15-23-25 (17-19)31-24-16-13-18-9-5-6-10-20 (18)26 (24)28 (23)22-12-8-7-11-21 (22)27 (30)32-28/h5-17H, 3-4H2, 1-2H3. HMNGPLGXLQFPFN-UHFFFAOYSA-N. >98.0%(GC)(T).
6H-Indolo[2,3-b]quinoxaline
6H-Indolo[2,3-b]quinoxaline. Group: Small molecule semiconductor building blocks. CAS No. 243-59-4. Product ID: 6H-indolo[3,2-b]quinoxaline. Molecular formula: 219.25. Mole weight: C14H9N3. C1=CC=C2C(=C1)C3=NC4=CC=CC=C4N=C3N2. InChI=1S/C14H9N3/c1-2-6-10-9 (5-1)13-14 (16-10)17-12-8-4-3-7-11 (12)15-13/h1-8H, (H, 16, 17). LCKIWLDOHFUYDV-UHFFFAOYSA-N. >98.0%(GC)(T).
7-Diethylamino-4-methylcoumarin (purified by sublimation)
7-diethylamino-4-methylcoumarin is a light tan grains. Gives bright blue-white fluorescence in very dilute solutions. (NTP, 1992);DryPowder. Group: other material building blocks. CAS No. 91-44-1. Product ID: 7-(diethylamino)-4-methylchromen-2-one. Molecular formula: 231.29g/mol. Mole weight: C14H17NO2. CCN(CC)C1=CC2=C(C=C1)C(=CC(=O)O2)C. InChI=1S/C14H17NO2/c1-4-15 (5-2)11-6-7-12-10 (3)8-14 (16)17-13 (12)9-11/h6-9H, 4-5H2, 1-3H3. AFYCEAFSNDLKSX-UHFFFAOYSA-N.
7-(Dimethylamino)-4-methylcoumarin (purified by sublimation)
7-(Dimethylamino)-4-methylcoumarin (purified by sublimation). Group: other material building blocks. CAS No. 87-01-4. Product ID: 7-(dimethylamino)-4-methylchromen-2-one. Molecular formula: 203.24g/mol. Mole weight: C12H13NO2. CC1=CC(=O)OC2=C1C=CC(=C2)N(C)C. InChI=1S/C12H13NO2/c1-8-6-12 (14)15-11-7-9 (13 (2)3)4-5-10 (8)11/h4-7H, 1-3H3. GZEYLLPOQRZUDF-UHFFFAOYSA-N.
7H-benzo[c]carbazole
7H-benzo[c]carbazole. Group: Small molecule semiconductor building blocks. Alternative Names: 3,4-Benzocarbazole. CAS No. 205-25-4. Product ID: 7H-benzo[c]carbazole. Molecular formula: 217.27. Mole weight: C16H11N. C1=CC=C2C(=C1)C=CC3=C2C4=CC=CC=C4N3. InChI=1S/C16H11N/c1-2-6-12-11 (5-1)9-10-15-16 (12)13-7-3-4-8-14 (13)17-15/h1-10, 17H. UGFOTZLGPPWNPY-UHFFFAOYSA-N. 99.5%+.
8-Amino-1-octanethiol hydrochloride. Group: Self-assembly materials. CAS No. 937706-44-0.
8arm-PEG10K 7arm-OH, 1arm-COOH
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000.
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG 7arm-OH, 1arm-COOH, tripentaerythritol core, 8arm PEG, 7arm-Hydroxyl, 1arm-Carboxyl. Molecular formula: average Mn 10000.
8arm-PEG10K-Acrylate
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000.
8arm-PEG10K-COOH, hexaglycerol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH, hexaglycerol core, 8arm-PEG-COOH. Molecular formula: average Mn 10000.
8arm-PEG10K-COOH, tripentaerythritol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH, tripentaerythritol core, 8arm-PEG-COOH. Molecular formula: average Mn 10000.
8arm-PEG10K-Maleimide
8arm-PEG10K-Maleimide. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8-arm PEG10K-Methacrylate (hexaglycerol core)
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000.
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 10000.
8arm-PEG10K-NH2, hexaglycerol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, hexaglycerol core, 8arm-PEG-NH2. Molecular formula: average Mn 10000.
8arm-PEG10K-NH2, tripentaerythritol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-NH2, 8arm-PEG-NH2, tripentaerythritol core. Molecular formula: average Mn 10000.
8-arm PEG10K-PCL2K-Acrylate
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8-arm PEG10K-PLA2K-Acrylate
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8arm-PEG10K-SH
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH. Molecular formula: average Mn 10000.
8arm-PEG10K-SH, tripentaerythritol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-SH, tripentaerythritol core, 8arm-PEG-SH. Molecular formula: average Mn 10000.
8arm-PEG10K-Succinimidyl Glutarate
8arm-PEG10K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8arm-PEG10K-Succinimidyl Succinate
8arm-PEG10K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8arm-PEG10K-Vinylsulfone, tripentaerythritol core
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-VS, 8arm-PEG-Vinylsulfone, tripentaerythritol core. Molecular formula: average Mn 10000.
8arm-PEG15K-Succinimidyl Glutarate
8arm-PEG15K-Succinimidyl Glutarate. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8arm-PEG15K-Succinimidyl Succinate
8arm-PEG15K-Succinimidyl Succinate. Group: Poly(ethylene glycol) and poly(ethylene oxide).
8arm-PEG20K 7arm-OH, 1arm-COOH
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Molecular formula: average Mn 20000.
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG 7arm-OH, 1arm-COOH, tripentaerythritol core, 8arm PEG, 7arm-Hydroxyl, 1arm-Carboxyl. Molecular formula: average Mn 20000.
8arm-PEG20K-Acrylate
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-Acrylate, hexaglycerol core. Molecular formula: average Mn 20000.
8arm-PEG20K-COOH
Polyethylene glycol (PEG) compounds contain a polyether unit, commonly expressed as R1-(O-CH2-CH2)n-O-R2. They are generally biocompatible, non-toxic and stable in both organic and aqueous solutions, and so are extensively used in biological applications, as well as nanotechnology and materials research. Proteins with PEG chain modifications and compounds encapsulated in PEG liposomes exhibit a longer half-life in vivo than their non-PEGylated counterparts, a phenomenon known as PEG shielding. Functionalised PEG lipids and phospholipids can be used for protein-PEG conjugation. Uses: Activated peg derivatives can be used to modify peptides, proteins, or in other bioconjugation applications. pegylated materials have found broad use in drug delivery systems, virology, and immunology, as the incorporation of peg improves pharmacological properties such as increased water solubility, enhanced resistance to degradation (protein hydrolysis), increased circulation half-life, and reduced antigenicity. in addition to pegylation, activated peg derivatives can also be used to form networks for tissue engineering or drug delivery applications, depending on the architecture and reactivity. Group: Poly(ethylene glycol) and poly(ethylene oxide). Alternative Names: 8arm-PEG-COOH. Molecular formula: average Mn 20000.